Meanwhile, the combination of epigallocatechin gallate and quercetin enhance ANXA5 to effectively inhibit colorectal cancer arrest at the G1 stage (Xue et al., 2009; Al-Ghamdi et al., 2021). This evidence concerns the gene ANXA5 and colorectal cancer.